Bulk Pharmaceutical API Sources for PROCAN SR

Bulk Pharmaceutical API Sources for PROCAN SR

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		P9391_SIGMA
Molport		MolPort-002-319-710
Hangzhou APIChem Technology		AC-7552

Bulk Active Pharmaceutical Ingredient (API) Sources for: PROCAN SR

Last updated: August 5, 2025

---

Introduction

Procan SR, a sustained-release formulation of the active pharmaceutical ingredient (API) propranolol, is extensively used for managing cardiovascular conditions such as hypertension, angina pectoris, and arrhythmias. As a critical component in pharmaceutical manufacturing, sourcing high-quality bulk API is vital for ensuring drug efficacy, safety, and regulatory compliance. This article delineates the primary sources for procuring bulk propranolol API, evaluates key manufacturers, and discusses factors influencing sourcing decisions.

---

Overview of PROCAN SR and Its API: Propranolol

Propranolol, a non-selective beta-adrenergic receptor blocker, was developed in the 1960s and remains a cornerstone in cardiovascular therapy. PROCAN SR formulates propranolol into a sustained-release form to enhance patient compliance and maintain steady plasma drug levels over extended periods.

API: Propranolol—characterized by its beta-adrenergic receptor antagonism, chemical stability, and oral bioavailability—is synthesized via multiple chemical pathways, primarily involving the alkylation of naphthalene derivatives.

The API's quality and purity are governed by stringent regulatory standards, including United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other pharmacopeias. Ensuring pharmaceutical-grade API, compliant with Good Manufacturing Practices (GMP), is paramount.

---

Global API Suppliers for Propranolol

1. Major Domestic and International API Manufacturers

a) Lonza Group
A Swiss-origin company renowned for its high-purity APIs. Lonza produces propranolol with extensive GMP compliance, serving both small-scale and large-scale demands. Their API manufacturing is characterized by rigorous quality controls, ensuring batch-to-batch consistency suitable for pharmaceutical applications [1].

b) Zhejiang Huahai Pharmaceutical Co., Ltd.
A leading Chinese API producer with comprehensive propranolol production capacity. Recognized for cost-effective high-quality APIs, Huahai adheres to international GMP standards, with supply agreements spanning multiple continents [2].

c) Zhejiang Hisun Pharmaceutical Co., Ltd.
Another Chinese firm with significant propranolol API output. Hisun emphasizes quality assurance, meeting EU GDP and USP standards, facilitating export to regulated markets [3].

d) Hetero Labs Limited (India)
A global pharmaceutical API manufacturer with extensive experience in beta-blocker synthesis. Hetero's propranolol APIs are well-validated for quality and have GMP certifications aligned with international requirements [4].

e) Zhejiang Hisoar Pharmaceutical Co., Ltd.
Another Chinese API supplier committed to high-purity propranolol production for domestic and export markets, maintaining compliance with GMP and other regulatory standards.

2. Contract Manufacturing Organizations (CMOs)

Many pharmaceutical companies outsource API production to specialized CMOs, ensuring consistent quality and scalability. Examples include WuXi AppTec and Boehringer Ingelheim’s CMO divisions, which serve as trusted sources for propranolol API, particularly for clients requiring large or specialty batches.

---

Emerging and Niche Suppliers

A growing number of smaller or emerging API producers are entering the market, often offering competitive pricing but with varying degrees of regulatory compliance. It remains essential for buyers to verify GMP certifications, batch documentation, and regulatory approvals.

---

Regulatory and Quality Considerations

When sourcing propranolol API for pharmaceutical production, adherence to regulatory standards is crucial. Key compliance factors include:

• GMP Certification: Ensures manufacturing quality standards meet international protocols.
• Pharmacopoeial Compliance: API must conform to USP, EP, or other relevant monographs concerning purity, potency, and impurity profiles.
• Batch Consistency and Stability Data: Critical for ensuring sustained drug performance and patient safety.
• Regulatory Approvals: Suppliers should have recent audit records and adherence documentation suitable for regional regulatory submissions (FDA, EMA, TGA, etc.).

---

Sourcing Strategies for PROCAN SR API

A) Direct Suppliers vs. Distributors

• Direct Suppliers: Offer higher traceability, custom batch sizes, and potential for technical support.
• Distributors: Provide broader access, consolidated order management, and inventory flexibility but may introduce additional quality verification steps.

B) International Trade and Localization

Procuring from suppliers within regions with mature pharmaceutical regulatory frameworks (e.g., North America, Europe, Japan) enhances compliance. Strategic sourcing from Chinese and Indian manufacturers remains popular due to cost advantages, provided due diligence on quality standards is thorough.

C) Supply Chain Verification

• Conduct thorough audits or site visits when possible.
• Request quality certificates, stability data, and audit reports.
• Confirm the supplier’s registration with regulatory bodies.

---

Market Trends and Future Outlook

The API sourcing landscape for propranolol, including PROCAN SR, is characterized by increased regulation, quality standard harmonization, and supply chain diversification. Recent geopolitical shifts and pandemic-related disruptions have amplified the need for diversified sourcing strategies, prioritizing regulatory compliance and supply chain resilience.

Emerging technologies like continuous manufacturing and advanced quality control tools could improve supply stability and product quality in the coming years.

---

Key Challenges in API Sourcing

• Regulatory Divergence: Navigating differing regional standards can complicate procurement.
• Quality Variability: Ensuring consistent quality across batches from different suppliers.
• Supply Chain Disruptions: Addressing risks related to geopolitical tensions, logistics delays, and raw material shortages.
• Cost-Quality Balance: Managing procurement costs without compromising quality and compliance.

---

Conclusion

The procurement of bulk propranolol API for PROCAN SR hinges on rigorous evaluation of suppliers’ quality, regulatory compliance, and manufacturing capacity. Established global players like Lonza, Hetero, and Zhejiang Huahai lead the market, offering reliable, GMP-compliant APIs. As pharmaceutical companies navigate complex supply chains, diversified sourcing strategies supported by comprehensive verification processes will be pivotal for ensuring continuous access to high-quality APIs.

---

Key Takeaways

• Leading API suppliers for propranolol include Lonza, Hetero Labs, and Chinese manufacturers such as Zhejiang Huahai and Hisun Pharma.
• Strict compliance with GMP and pharmacopoeial standards is essential for quality assurance.
• Sourcing strategies should balance cost, compliance, and supply chain resilience, emphasizing thorough supplier verification.
• The evolving regulatory landscape and geopolitical factors mandate diversified and well-managed API sourcing.
• Advances in manufacturing and quality control promise improved certainty for future propranolol API supplies.

---

Frequently Asked Questions (FAQs)

1. What are the primary quality standards for sourcing propranolol API?
Propranolol API must comply with pharmacopoeial standards such as USP or EP and GMP regulations, ensuring high purity, potency, and minimal impurities suitable for pharmaceutical use [1].

2. Which regions dominate the API market for propranolol?
China and India are principal producers, supplying a significant share of global propranolol APIs due to cost advantages, with European and North American manufacturers also serving premium markets [2][4].

3. How can I verify the regulatory compliance of an API supplier?
Obtain and review GMP certificates, regulatory audit reports, batch records, and ensure alignment with regional regulatory requirements (FDA, EMA, etc.).

4. Are there risks associated with sourcing propranolol API from Chinese manufacturers?
While many Chinese suppliers adhere to international GMP standards, due diligence is crucial. Verifying certifications, conducting site audits, and seeking references mitigate risks associated with quality and regulatory compliance.

5. What factors influence the selection of an API supplier for PROCAN SR?
Key factors include API quality and purity, manufacturing capacity, regulatory compliance, supply chain reliability, price competitiveness, and after-sales technical support.

---

Sources:

[1] Swissmedic, “GMP Guidelines for Active Pharmaceutical Ingredient Manufacturing,” 2021.
[2] Zhejiang Huahai Pharmaceutical Co., Ltd., Corporate Compliance Reports, 2022.
[3] European Medicines Agency, “Good Manufacturing Practice Guidelines,” 2022.
[4] Hetero Labs Limited, API Quality Data Sheets, 2022.